Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 16, 2007
Grant Date -
Oct 28, 2004
app pub date -
Mar 5, 2004
filing date -
Mar 12, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to benzimidazole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully